%0 Journal Article
%T Risk of contralateral breast cancer amongst BRCA1/2 mutation carriers
%A Nath Basu, Narendra
%A Evans, D. Gareth
%J Translational Cancer Research
%D 2016
%B 2016
%9 
%! Risk of contralateral breast cancer amongst BRCA1/2 mutation carriers
%K 
%X Women harbouring a deleterious mutation in the high penetrance BRCA1/2 genes have a lifetime risk of up to 85% of developing breast cancer (1). Once diagnosed, they have a significant risk of developing a contralateral breast cancer—approximately 2–3% per year. This risk persists for up to 30 years following an initial breast cancer diagnosis (2).
%U https://tcr.amegroups.org/article/view/10640
%P S1066-S1069
%@ 2219-6803